Computational model for drug resistance assessment can improve treatment for leukemia and lung cancer

byLinnaeus UniversityCredit: Unsplash/CC0 Public DomainA new method can improve treatment for patients with chronic myeloid leukemia by predicting which medication will be most effective. The me

Updated on: December 21,2024 0

Computational model for drug resistance assessment can improve treatment for leukemia and lung cancer

byLinnaeus UniversityCredit: Unsplash/CC0 Public DomainA new method can improve treatment for patients with chronic myeloid leukemia by predicting which medication will be most effective. The me

Updated on:December 21,2024 0

Reactive cysteines on peptide antigens may unlock new cancer immunotherapy possibilities

by Olivia Dimmer,Northwestern UniversityDevelopment of cell-impermeable cysteine-reactive probes. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54139-8Northwestern Medi

Updated on: January 22,2025 0

Reactive cysteines on peptide antigens may unlock new cancer immunotherapy possibilities

by Olivia Dimmer,Northwestern UniversityDevelopment of cell-impermeable cysteine-reactive probes. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54139-8Northwestern Medi

Updated on:January 22,2025 0

Engineered CAR-NK cells offer an alternative approach to fighting leukemia

Engineered CAR-NK cells offer an alternative approach to fighting leukemiaby Markus Bernards,Goethe University Frankfurt am MainGeneration process and evaluation of CRISPR/Cas9 knockout for CAR3

Updated on: January 22,2025 0

Engineered CAR-NK cells offer an alternative approach to fighting leukemia

Engineered CAR-NK cells offer an alternative approach to fighting leukemiaby Markus Bernards,Goethe University Frankfurt am MainGeneration process and evaluation of CRISPR/Cas9 knockout for CAR3

Updated on:January 22,2025 0

A step towards personalized immunotherapy: MIRO device replicates tumors, environments and interactions

Updated on: April 01,2025 0

A step towards personalized immunotherapy: MIRO device replicates tumors, environments and interactions

Updated on:April 01,2025 0

Could a pill replace gene therapy for sickle cell disease? Research uncovers potential path to small-molecule drug

by Nancy Fliesler,Children's Hospital BostonNew work suggests ways to target the BCL11A protein with drugs, enabling patients with sickle cell disease to produce non-sickling fetal hemoglobi

Updated on: January 17,2025 0

Could a pill replace gene therapy for sickle cell disease? Research uncovers potential path to small-molecule drug

by Nancy Fliesler,Children's Hospital BostonNew work suggests ways to target the BCL11A protein with drugs, enabling patients with sickle cell disease to produce non-sickling fetal hemoglobi

Updated on:January 17,2025 0

Neurocognitive battery feasible in 3-year-olds during leukemia treatment

by Elana GotkineA brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to a studypublishedonline Dec. 9 inPediatri

Updated on: January 22,2025 0

Neurocognitive battery feasible in 3-year-olds during leukemia treatment

by Elana GotkineA brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to a studypublishedonline Dec. 9 inPediatri

Updated on:January 22,2025 0

How breast cancer cells survive in bone marrow after remission

byUniversity of MichiganGraphical abstract. Credit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI170953A study from researchers at the University of Michigan and the Unive

Updated on: December 21,2024 0

How breast cancer cells survive in bone marrow after remission

byUniversity of MichiganGraphical abstract. Credit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI170953A study from researchers at the University of Michigan and the Unive

Updated on:December 21,2024 0

Immunosuppression study helps understand why some prostate cancer treatments do not work as expected

byTampere UniversityOn the left is a tissue sample from the prostate stained with hematoxylin and eosin. Hematoxylin stains the nuclei blue or purple because it binds to DNA, and eosin stains th

Updated on: December 21,2024 0

Immunosuppression study helps understand why some prostate cancer treatments do not work as expected

byTampere UniversityOn the left is a tissue sample from the prostate stained with hematoxylin and eosin. Hematoxylin stains the nuclei blue or purple because it binds to DNA, and eosin stains th

Updated on:December 21,2024 0

Researchers explore e-bikes for cancer recovery

by Patty Wellborn,University of British ColumbiaOutline of the CRANK intervention development. APEASE: Acceptability, Practicability, Effectiveness, Affordability, Side-Effects, and Equity; BCT:

Updated on: December 20,2024 0

Researchers explore e-bikes for cancer recovery

by Patty Wellborn,University of British ColumbiaOutline of the CRANK intervention development. APEASE: Acceptability, Practicability, Effectiveness, Affordability, Side-Effects, and Equity; BCT:

Updated on:December 20,2024 0

Reducing dose of popular blood thinners may limit risk of future bleeding, study finds

byUniversity of MichiganCredit: Pixabay/CC0 Public DomainFor people taking popular blood thinners after having a blood clot, a reduced dose may limit the future risk of bleeding as well as hospi

Updated on: January 17,2025 0

Reducing dose of popular blood thinners may limit risk of future bleeding, study finds

byUniversity of MichiganCredit: Pixabay/CC0 Public DomainFor people taking popular blood thinners after having a blood clot, a reduced dose may limit the future risk of bleeding as well as hospi

Updated on:January 17,2025 0

Natural killer cells offer hope for hard-to-treat pediatric sarcomas

byUniversity of QueenslandEphrin type-A receptor-2 (EphA2) and natural killer (NK) cell infiltration correspond with sarcoma survival. Credit:Clinical and Translational Medicine(2025

Updated on: February 20,2025 0

Natural killer cells offer hope for hard-to-treat pediatric sarcomas

byUniversity of QueenslandEphrin type-A receptor-2 (EphA2) and natural killer (NK) cell infiltration correspond with sarcoma survival. Credit:Clinical and Translational Medicine(2025

Updated on:February 20,2025 0

Survival rates for incurable larynx cancer investigated for first time

byNewcastle UniversityKaplan Meier Survival Curves with associated estimated survival rates for entire cohort. Credit:Clinical Otolaryngology(2024). DOI: 10.1111/coa.14260First-of-it

Updated on: January 21,2025 0

Survival rates for incurable larynx cancer investigated for first time

byNewcastle UniversityKaplan Meier Survival Curves with associated estimated survival rates for entire cohort. Credit:Clinical Otolaryngology(2024). DOI: 10.1111/coa.14260First-of-it

Updated on:January 21,2025 0